Left Atrial Appendage Closure Global Market by Product, Trends, Analysis and Forecasts to 2020
ReportsWeb.com published “Left Atrial Appendage Closure Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this Market.
(EMAILWIRE.COM, May 05, 2017 ) Publisher's market research analyst predicts that the global left atrial appendage closure market will grow at a CAGR of approximately 28% by 2020. The recent increase in new product approvals by regulating bodies such as the FDA is one of the major reasons for the rising market demand. The growing focus on clinical trials by vendors that results in increased number of new product approvals and launches is also expected to augment market growth.
Increasing incidences of stroke among the populace is the key driver for the growth of this market. Stroke is a medical condition that is common in people suffering from diabetes and cardiovascular diseases. The ability of left atrial appendage (LAA) closure devices to close off the LAA, so as to reduce the risk of stroke is a critical factor that impels the adoption of such devices during the predicted period.
For more information http://www.reportsweb.com/global-left-atrial-appendage-laa-closure-market-2016-2020
Geographical segmentation of the left atrial appendage closure market
- Americas
- APAC
- EMEA
Publisher market research analysts estimate the EMEA region to be the largest market for LAA closure devices during the forecast period. The recent increase in the incidence of stroke coupled with the growing elderly population in this region is a significant factor that fosters market growth during the forecast period.
Product-based segmentation of the left atrial appendage closure market
- Epicardial LAA closure device
- Endocardial LAA closure device
The epicardial LAA closure devices segment involves percutaneous closed-chest epicardial LAA ligation and offers advantages like short-term systemic anticoagulation. The ability of such devices to avoid post-implantation procedures is a major factor that augments its adoption during the forecast period.
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001202183/sample
Competitive landscape and key vendors
The global LAA closure market is competitive and is primarily dominated by vendors like Atricure and Boston Scientific. Since this market is consolidated, only a few vendors that have the ability to provide products to the international market can survive and succeed during the forecast period.
The leading vendors in the market are -
- Boston Scientific
- St. Jude Medical
- AtriCure
- Coherex Medical
Other prominent vendors in the market include Lifetech Scientific, SentreHEART, Occlutech and Lifetech Scientific
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001202183/buying
Increasing incidences of stroke among the populace is the key driver for the growth of this market. Stroke is a medical condition that is common in people suffering from diabetes and cardiovascular diseases. The ability of left atrial appendage (LAA) closure devices to close off the LAA, so as to reduce the risk of stroke is a critical factor that impels the adoption of such devices during the predicted period.
For more information http://www.reportsweb.com/global-left-atrial-appendage-laa-closure-market-2016-2020
Geographical segmentation of the left atrial appendage closure market
- Americas
- APAC
- EMEA
Publisher market research analysts estimate the EMEA region to be the largest market for LAA closure devices during the forecast period. The recent increase in the incidence of stroke coupled with the growing elderly population in this region is a significant factor that fosters market growth during the forecast period.
Product-based segmentation of the left atrial appendage closure market
- Epicardial LAA closure device
- Endocardial LAA closure device
The epicardial LAA closure devices segment involves percutaneous closed-chest epicardial LAA ligation and offers advantages like short-term systemic anticoagulation. The ability of such devices to avoid post-implantation procedures is a major factor that augments its adoption during the forecast period.
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001202183/sample
Competitive landscape and key vendors
The global LAA closure market is competitive and is primarily dominated by vendors like Atricure and Boston Scientific. Since this market is consolidated, only a few vendors that have the ability to provide products to the international market can survive and succeed during the forecast period.
The leading vendors in the market are -
- Boston Scientific
- St. Jude Medical
- AtriCure
- Coherex Medical
Other prominent vendors in the market include Lifetech Scientific, SentreHEART, Occlutech and Lifetech Scientific
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001202183/buying
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results